These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35008554)

  • 1. Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment.
    Sovova Z; Pecankova K; Majek P; Suttnar J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families.
    Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P
    Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
    Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
    J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
    Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
    Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital fibrinogen disorders: an update.
    de Moerloose P; Casini A; Neerman-Arbez M
    Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review.
    Li Y; Ding B; Wang X; Ding Q
    Thromb Res; 2022 Sep; 217():36-47. PubMed ID: 35853369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
    Neerman-Arbez M; de Moerloose P; Casini A
    Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
    Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A
    Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of congenital fibrinogen disorders.
    Lebreton A; Casini A
    Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital structural and functional fibrinogen disorders: a primer for internists.
    Undas A; Casini A
    Pol Arch Intern Med; 2019 Dec; 129(12):913-920. PubMed ID: 31797863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen αC domain: Its importance in physiopathology.
    Soria J; Mirshahi S; Mirshahi SQ; Varin R; Pritchard LL; Soria C; Mirshahi M
    Res Pract Thromb Haemost; 2019 Apr; 3(2):173-183. PubMed ID: 31011701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
    Simurda T; Zolkova J; Snahnicanova Z; Loderer D; Skornova I; Sokol J; Hudecek J; Stasko J; Lasabova Z; Kubisz P
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Variants in the
    Simurda T; Brunclikova M; Asselta R; Caccia S; Zolkova J; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare inherited disorders of fibrinogen.
    Acharya SS; Dimichele DM
    Haemophilia; 2008 Nov; 14(6):1151-8. PubMed ID: 19141154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
    Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P
    J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management.
    Simurda T; Asselta R; Zolkova J; Brunclikova M; Dobrotova M; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
    Castaman G; Giacomelli SH; Biasoli C; Contino L; Radossi P
    Eur J Haematol; 2019 Oct; 103(4):379-384. PubMed ID: 31314131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia.
    Simurda T; Zolkova J; Kolkova Z; Loderer D; Dobrotova M; Skornova I; Brunclíkova M; Grendar M; Lasabova Z; Stasko J; Kubisz P
    Int J Hematol; 2020 Jun; 111(6):795-802. PubMed ID: 32166693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of dysfibrinogenemia in pregnancy: A case report.
    Yan J; Deng D; Cheng P; Liao L; Luo M; Lin F
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28948631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Management of Congenital Fibrinogen Deficiencies.
    Casini A; de Moerloose P; Neerman-Arbez M
    Semin Thromb Hemost; 2016 Jun; 42(4):366-74. PubMed ID: 27019462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.